Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms
- PMID: 25496113
- DOI: 10.1021/ar500356n
Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms
Abstract
CONSPECTUS: This Account highlights recent advances and discusses major challenges in the field of drug-target recognition, binding, and unbinding studied using metadynamics-based approaches, with particular emphasis on their role in structure-based design. Computational chemistry has significantly contributed to drug design and optimization in an extremely broad range of areas, including prediction of target druggability and drug likeness, de novo design, fragment screening, ligand docking, estimation of binding affinity, and modulation of ADMET (absorption, distribution, metabolism, excretion, toxicity) properties. Computationally driven drug discovery must continuously adapt to keep pace with the evolving knowledge of the factors that modulate the pharmacological action of drugs. There is thus an urgent need for novel computational approaches that integrate the vast amount of complex information currently available for small (bio)organic compounds, biologically relevant targets and their complexes, while also accounting accurately for the thermodynamics and kinetics of drug-target association, the intrinsic dynamical behavior of biomolecular systems, and the complexity of protein-protein networks. Understanding the mechanism of drug binding to and unbinding from biological targets is fundamental for optimizing lead compounds and designing novel biologically active ones. One major challenge is the accurate description of the conformational complexity prior to and upon formation of drug-target complexes. Recently, enhanced sampling methods, including metadynamics and related approaches, have been successfully applied to investigate complex mechanisms of drugs binding to flexible targets. Metadynamics is a family of enhanced sampling techniques aimed at enhancing the rare events and reconstructing the underlying free energy landscape as a function of a set of order parameters, usually referred to as collective variables. Studies of drug binding mechanisms have predicted the most probable association and dissociation pathways and the related binding free energy profile. In addition, the availability of an efficient open-source implementation, running on cost-effective GPU (i.e., graphical processor unit) architectures, has considerably decreased the learning curve and the computational costs of the methods, and increased their adoption by the community. Here, we review the recent contributions of metadynamics and other enhanced sampling methods to the field of drug-target recognition and binding. We discuss how metadynamics has been used to search for transition states, to predict binding and unbinding paths, to treat conformational flexibility, and to compute free energy profiles. We highlight the importance of such predictions in drug discovery. Major challenges in the field and possible solutions will finally be discussed.
Similar articles
-
Ligand-Binding Calculations with Metadynamics.Methods Mol Biol. 2019;2022:233-253. doi: 10.1007/978-1-4939-9608-7_10. Methods Mol Biol. 2019. PMID: 31396906
-
Understanding the challenges of protein flexibility in drug design.Expert Opin Drug Discov. 2015 Dec;10(12):1301-13. doi: 10.1517/17460441.2015.1094458. Epub 2015 Sep 28. Expert Opin Drug Discov. 2015. PMID: 26414598 Review.
-
Using metadynamics and path collective variables to study ligand binding and induced conformational transitions.Methods Mol Biol. 2012;819:501-13. doi: 10.1007/978-1-61779-465-0_29. Methods Mol Biol. 2012. PMID: 22183554
-
Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.Chem Res Toxicol. 2011 Sep 19;24(9):1420-56. doi: 10.1021/tx200211v. Epub 2011 Jul 26. Chem Res Toxicol. 2011. PMID: 21790149 Review.
-
Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.ACS Chem Biol. 2009 Apr 17;4(4):249-60. doi: 10.1021/cb800299s. Epub 2009 Feb 4. ACS Chem Biol. 2009. PMID: 19193052
Cited by
-
Binding of Carbon Monoxide to Hemoglobin in an Oxygen Environment: Force Field Development for Molecular Dynamics.J Chem Theory Comput. 2024 May 28;20(10):4229-4238. doi: 10.1021/acs.jctc.4c00029. Epub 2024 Feb 24. J Chem Theory Comput. 2024. PMID: 38400860 Free PMC article.
-
APP-C31: An Intracellular Promoter of Both Metal-Free and Metal-Bound Amyloid-β40 Aggregation and Toxicity in Alzheimer's Disease.Adv Sci (Weinh). 2024 Jan;11(4):e2307182. doi: 10.1002/advs.202307182. Epub 2023 Nov 10. Adv Sci (Weinh). 2024. PMID: 37949680 Free PMC article.
-
Targeted Protein Degradation: Advances, Challenges, and Prospects for Computational Methods.J Chem Inf Model. 2023 Sep 11;63(17):5408-5432. doi: 10.1021/acs.jcim.3c00603. Epub 2023 Aug 21. J Chem Inf Model. 2023. PMID: 37602861 Free PMC article. Review.
-
Inhibition of 3-Hydroxykynurenine Transaminase from Aedes aegypti and Anopheles gambiae: A Mosquito-Specific Target to Combat the Transmission of Arboviruses.ACS Bio Med Chem Au. 2023 Feb 16;3(2):211-222. doi: 10.1021/acsbiomedchemau.2c00080. eCollection 2023 Apr 19. ACS Bio Med Chem Au. 2023. PMID: 37101811 Free PMC article.
-
Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations.J Chem Inf Model. 2023 May 8;63(9):2842-2856. doi: 10.1021/acs.jcim.3c00042. Epub 2023 Apr 13. J Chem Inf Model. 2023. PMID: 37053454 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical